| BRCA mutations in ovarian and prostate cancer: bench to bedside S Boussios, E Rassy, M Moschetta, A Ghose, S Adeleke, E Sanchez, ... Cancers 14 (16), 3888, 2022 | 105 | 2022 |
| Applications of proteomics in ovarian cancer: dawn of a new era A Ghose, SVN Gullapalli, N Chohan, A Bolina, M Moschetta, E Rassy, ... Proteomes 10 (2), 16, 2022 | 101 | 2022 |
| Recent insights into PARP and immuno-checkpoint inhibitors in epithelial ovarian cancer A Revythis, A Limbu, C Mikropoulos, A Ghose, E Sanchez, M Sheriff, ... International journal of environmental research and public health 19 (14), 8577, 2022 | 89 | 2022 |
| BRCA mutations in prostate cancer: assessment, implications and treatment considerations S Shah, R Rachmat, S Enyioma, A Ghose, A Revythis, S Boussios International Journal of Molecular Sciences 22 (23), 12628, 2021 | 82 | 2021 |
| Advances in ovarian cancer treatment beyond PARP inhibitors F Aliyuda, M Moschetta, A Ghose, K Sofia Rallis, M Sheriff, E Sanchez, ... Current Cancer Drug Targets 23 (6), 433-446, 2023 | 68 | 2023 |
| Genetic aberrations of DNA repair pathways in prostate cancer: translation to the clinic A Ghose, M Moschetta, G Pappas-Gogos, M Sheriff, S Boussios International Journal of Molecular Sciences 22 (18), 9783, 2021 | 58 | 2021 |
| Hereditary ovarian cancer: towards a cost-effective prevention strategy A Ghose, A Bolina, I Mahajan, SA Raza, M Clarke, A Pal, E Sanchez, ... International Journal of Environmental Research and Public Health 19 (19), 12057, 2022 | 55 | 2022 |
| New surgical robots on the horizon and the potential role of artificial intelligence G Aruni, G Amit, P Dasgupta Investigative and clinical urology 59 (4), 221-222, 2018 | 52 | 2018 |
| Exosomes in the diagnosis and treatment of renal cell cancer S Boussios, P Devo, ICA Goodall, K Sirlantzis, A Ghose, SD Shinde, ... International journal of molecular sciences 24 (18), 14356, 2023 | 41 | 2023 |
| Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4 A Ghose, L McCann, S Makker, U Mukherjee, SVN Gullapalli, J Erekkath, ... Therapeutic advances in medical oncology 16, 17588359241233225, 2024 | 36 | 2024 |
| Renal cell cancer–insights in drug resistance mechanisms H Aweys, D Lewis, M Sheriff, RD Rabbani, P Lapitan, E Sanchez, ... Anticancer Research 43 (11), 4781-4792, 2023 | 28 | 2023 |
| Advances in adoptive T-cell therapy for metastatic melanoma A Das, A Ghose, K Naicker, E Sanchez, C Chargari, E Rassy, S Boussios Current Research in Translational Medicine, 103404, 2023 | 22 | 2023 |
| Neoadjuvant Chemo-Immunotherapy for Early-Stage Non–Small Cell Lung Cancer: A Systematic Review and Meta-Analysis GL Banna, MA Hassan, A Signori, EF Giunta, A Maniam, S Anpalakhan, ... JAMA Network Open 7 (4), e246837-e246837, 2024 | 20 | 2024 |
| The Experience of a Single NHS England Trust on the Impact of the COVID-19 Pandemic on Junior and Middle-Grade Doctors: What Is Next? A Revythis, S Shah, S Enyioma, A Ghose, M Patel, A Karathanasi, ... International Journal of Environmental Research and Public Health 18 (19), 10413, 2021 | 18 | 2021 |
| Hallmarks of the tumour microenvironment of gliomas and its interaction with emerging immunotherapy modalities CA Linares, A Varghese, A Ghose, SD Shinde, S Adeleke, E Sanchez, ... International Journal of Molecular Sciences 24 (17), 13215, 2023 | 17 | 2023 |
| Efficacy and safety of COVID-19 vaccines—an update E Sharma, S Revinipati, S Bhandari, S Thakur, S Goyal, A Ghose, ... Diseases 10 (4), 112, 2022 | 16 | 2022 |
| The increasing indications of FDG-PET/CT in the staging and management of Invasive Bladder Cancer NP Omorphos, A Ghose, JDB Hayes, A Kandala, P Dasgupta, A Sharma, ... Urologic Oncology: Seminars and Original Investigations 40 (10), 434-441, 2022 | 14 | 2022 |
| Melanoma—the therapeutic considerations in the clinical practice S Adeleke, S Okoli, A Augustine, J Galante, A Agnihotri, M Uccello, ... Annals of Palliative Medicine 12 (6), 1355372-1351372, 2023 | 13 | 2023 |
| Clinico-pathological factors determining recurrence of phyllodes tumors of the breast: the 25-year experience at a tertiary cancer centre B Sain, A Gupta, A Ghose, S Halder, V Mukherjee, S Bhattacharya, ... Journal of Personalized Medicine 13 (5), 866, 2023 | 12 | 2023 |
| COVID-19, mucormycosis and cancer: The triple threat—Hypothesis or reality? I Mahajan, A Ghose, D Gupta, M Manasvi, S Bhandari, A Das, E Sanchez, ... Journal of Personalized Medicine 12 (7), 1119, 2022 | 11 | 2022 |
Stergios BoussiosProfessor of Medical Oncology在 nhs.net 的电子邮件经过验证
